ELMDNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends June 30

Electromed, Inc.

Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Aug 25, 2026

$27.40−0.02 (-0.07%)

Close on Oct 19, 2026

Market cap: $239.32M
P/E (TTM): 21.1
Dividend yield: –

Electromed, Inc. income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2026 2026-06-30	FY 2025 2025-06-30	FY 2024 2024-06-30	FY 2023 2023-06-30	FY 2022 2022-06-30	FY 2021 2021-06-30	FY 2020 2020-06-30	FY 2019 2019-06-30	FY 2018 2018-06-30	FY 2017 2017-06-30	FY 2016 2016-06-30	FY 2015 2015-06-30	FY 2014 2014-06-30	FY 2013 2013-06-30	FY 2012 2012-06-30	FY 2011 2011-06-30
Revenue	74	64	55	48	42	36	32	31	28	26	23	19	15	15	20	19
Cost of Revenue	16	14	13	12	10	8.45	7.27	7.45	6.53	5.29	5.12	5.81	4.85	4.66	5.38	5.23
Gross Profit	58	50	42	37	31	27	25	24	22	21	18	14	11	10	14	14
Research & Development	1.31	1.00	0.66	0.92	1.36	1.72	1.05	0.58	0.25	0.60	0.38	0.32	0.47	0.60	0.92	1.03
Selling, General & Admin	43	39	34	32	27	22	20	20	19	16	14	12	11	12	13	11
Advertising Expenses	1.68	1.42	1.49	1.24	0.94	1.06	0.78	0.58	0.47	0.38	0.33	0.34	0.50	0.63	0.78	0.66
Operating Expenses	44	40	35	33	28	24	20	21	19	17	15	12	11	12	14	12
Operating Income	14	9.66	6.58	4.01	2.97	3.14	5.12	2.83	2.71	3.57	3.11	1.31	-0.74	-1.83	0.61	1.87
Interest Expense	–	–	–	–	–	–	–	–	–	–	–	0.09	0.08	0.12	0.17	0.19
Interest & Investment Income	–	–	–	–	–	–	–	–	–	0.02	0.01	0.00	0.01	0.02	0.01	0.01
Asset Impairment Charges	–	–	–	–	–	–	–	–	–	–	0.02	0.12	–	–	–	–
Gain (Loss) on Sale of Assets	–	–	–	–	–	–	0.00	-0.01	-0.03	0.00	-0.04	-0.30	-0.14	-0.05	-0.05	-0.03
Legal Settlements	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0	-0.28
Pretax Income	14	10	7.04	4.09	3.00	3.17	5.24	2.92	2.73	3.52	3.04	1.22	-0.82	-1.94	0.44	1.68
Income Tax Expense	3.06	2.75	1.89	0.92	0.69	0.81	1.08	0.94	0.90	1.29	0.83	0.13	0.47	-0.62	0.25	0.62
Income from Continuing Operations	–	–	–	–	–	–	–	–	–	–	–	1.09	-1.29	-1.33	0.19	1.06
Net Income	11	7.54	5.15	3.17	2.31	2.36	4.16	1.98	1.83	2.23	2.21	1.09	-1.29	-1.33	0.19	1.06
EPS (Basic)(per share)	1.37	0.89	0.60	0.37	0.27	0.28	0.50	0.24	0.22	0.27	0.27	0.13	-0.16	-0.16	0.02	0.14
EPS (Diluted)(per share)	1.30	0.85	0.58	0.36	0.26	0.27	0.47	0.23	0.21	0.26	0.27	0.13	-0.16	-0.16	0.02	0.13
Shares Outstanding (Basic, Weighted)(shares)	8.27	8.45	8.56	8.46	8.47	8.57	8.40	8.31	8.21	8.17	8.14	8.12	8.11	8.11	8.11	7.82
Shares Outstanding (Diluted, Weighted)(shares)	8.69	8.91	8.86	8.70	8.77	8.91	8.83	8.63	8.62	8.46	8.25	8.15	8.11	8.11	8.11	7.84
Net Interest Income	–	–	0.46	0.08	0.03	0.03	0.12	0.09	0.02	-0.05	-0.07	-0.09	–	–	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 78.5%
Operating margin: 18.8%
Net margin: 15.3%
Return on equity, FY2026: 23.3%

Financial strength

Current ratio: 4.69
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 167.3%

Valuation

P/E ratio: 21.1
Price to sales: 3.24
Price to book: 4.43
Dividend yield: –